FDA Inspection 1036694 — Zhejiang Chiral Medicine Chemicals Co., Ltd.
The FDA completed an inspection of Zhejiang Chiral Medicine Chemicals Co., Ltd. on Oct 13, 2017 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 13, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)